Invasive pulmonary aspergillosis poses a major threat, especially to immunocompromised individuals such as tumor patients. The mortality rate is over 60%, and diagnosis and treatment of the fungal infection are often difficult. An expert presented new findings and gave practical advice for the care of these patients.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Alzheimer
Simplification and support of diagnostics through blood tests
- Primary biliary cholangitis
Therapy slows down liver damage
- Rheumatoid arthritis
Using predictors to improve therapy management
- Post-COVID
Complaints from a neurological point of view
- Type 2 diabetes, high blood pressure and cardiovascular risk
SGLT2 inhibitors are also a matter of the heart
- Clinical suspicion of Borrelia infection
When is a serological clarification useful?
- Tumor breakthrough pain
Quick help for a troublesome side effect
- Epilepsy